Dr. Maxwell Sauder is a Toronto-based dermatologist and Assistant Professor at the University of Toronto whose clinical and research work spans both inflammatory skin disease and onco-dermatology. His practice includes expertise in psoriasis, atopic dermatitis, prurigo nodularis, vitiligo, and other chronic inflammatory dermatoses, as well as the management of skin reactions related to cancer therapies, including immunotherapy- and EGFR inhibitor–associated eruptions, psoriasis, and other complex cutaneous toxicities. Dr. Sauder leads an active clinical trials program and has participated in more than 50 studies focused primarily on inflammatory skin disease, including psoriasis, atopic dermatitis, prurigo nodularis, and vitiligo. His research has included emerging biologics, small molecules, comparative effectiveness studies, and real-world outcomes. He has authored more than 50 peer-reviewed publications, including work published in leading journals such as The New England Journal of Medicine, The Lancet, and JAMA Dermatology. Dr. Sauder completed his medical degree at McMaster University, dermatology residency at the University of Ottawa, and fellowship training in cutaneous oncology at the Dana-Farber Cancer Institute and Harvard Medical School. He currently practices at the Princess Margaret Cancer Centre as an oncodermatologist. He is actively involved in leadership through the Canadian Dermatology Association, the Ontario Medical Association Section of Dermatology, and the Dermatology Association of Ontario.